Učitavanje...
TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10
Clinical approaches to treat advanced melanoma include immune therapies, whose benefits depend on tumor-reactive T-cell infiltration of metastases. However, most tumors lack significant immune infiltration prior to therapy. Selected chemokines promote T-cell migration into tumors; thus, agents that...
Spremljeno u:
| Izdano u: | Int J Cancer |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4497924/ https://ncbi.nlm.nih.gov/pubmed/25765738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.29515 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|